Meda Scoops Up Asthma Inhaler Maker For $135M
Swedish pharmaceutical company Meda AB will buy Acton Pharmaceuticals Inc. for $135 million, an addition driven largely by the Massachusetts company's newly approved steroid-containing asthma inhaler, it said Friday....To view the full article, register now.
Already a subscriber? Click here to view full article